EPIRUS Biopharmaceuticals, Inc. Accretion Expense
EPIRUS Biopharmaceuticals, Inc. reported Accretion Expense of $117.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2016-05-10
- EPIRUS Biopharmaceuticals, Inc. accretion expense for the quarter ending 2016-03-31 was $117.00K.
- EPIRUS Biopharmaceuticals, Inc. accretion expense for fiscal 2015 was $170.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 12 month |
|---|---|---|
| 2016-03-31 | $117.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $170.00K 10-K · filed 2016-03-29 |